[HTML][HTML] A second WNT for old drugs: drug repositioning against WNT-dependent cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - mdpi.com
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - pubmed.ncbi.nlm.nih.gov
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

[HTML][HTML] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - ncbi.nlm.nih.gov
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

[PDF][PDF] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - cancer - scienceopen.com
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers.

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - folia.unifr.ch
English Aberrant WNT signaling underlies cancerous transformation and growth in many
tissues, such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a …

[引用][C] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, H Shaw, A Koval, V Katanaev - Cancers, 2016 - cir.nii.ac.jp
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers.

K Ahmed, HV Shaw, A Koval, VL Katanaev - Cancers, 2016 - europepmc.org
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

[PDF][PDF] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - cancer - core.ac.uk
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

[PDF][PDF] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - cancer - access.archive-ouverte.unige.ch
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …

[PDF][PDF] A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

K Ahmed, HV Shaw, A Koval, VL Katanaev - cancer - researchgate.net
Aberrant WNT signaling underlies cancerous transformation and growth in many tissues,
such as the colon, breast, liver, and others. Downregulation of the WNT pathway is a desired …